The EMA has now issued a draft guidance on quality aspects of phage therapy medicinal products. Rising antimicrobial resistance has renewed interest in bacteriophages to fight pathogens.
- A Multi-Omics Approach For Characterizing Clinical-Scale iPSC Batches
- Global Implications Of Zero Tariffs On Indian Pharma Exports To China
- Why Do So Few Cell Therapies Make The Leap From Lab To GMP?
- Process Validation: Working Toward Harmonization Of Terms Used To Identify Validation Lots
- Careful Outsourcing Proves Key To Targeted Protein Degradation Drug Development
- What Can The Tech Sector's 'Minimally Viable' Concept Teach Biopharma?
- What Biotech Sponsors Should Look For In A CDMO For Sterile Fill/Finish
- New Group Wants 'Phase-Appropriate' Thinking To Retire
ON-DEMAND WEBINARS
The COVID-19 global pandemic took the world by storm, disrupting several industries and our global supply chains. Learn why having a contingency plan and proactively planning gives a company a competitive edge.
Consider these strategies when anticipating and mitigating disruptions, and how future innovations and trends will continue to shape the logistics industry.
Gain a deeper understanding of current directives and metrics to equip your team with the knowledge necessary to navigate the evolving landscape of sustainability.
The complexities of sample collection and logistics in advanced therapy studies naturally brings chain of custody challenges in protecting the integrity of a trials’ high value samples. Learn about end to end sample management strategies, logistical integration planning, real-time tracking and LIVE monitoring technologies.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1572384472 recall, packaging, shipping]( "Risk Mitigation Planning For Pharmaceutical Tariffs")
Risk Mitigation Planning For Pharmaceutical TariffsExamine the potential ramifications of proposed tariffs on the pharmaceutical and biotechnology sectors, highlighting critical concerns regarding national security and supply chain stability.
-
![GettyImages-1693748594 phone]( "RTSM: Randomization And Cohort Management, IP Inventory Management")
RTSM: Randomization And Cohort Management, IP Inventory ManagementSignant’s SmartSignals® RTSM solution helped an innovative biopharmaceutical company secure an FDA Orphan Drug designation for its cardiomyopathy drug.
-
![GettyImages-970394878-genetic-engineering-gene-editing-dna]( "Inside A Gene Therapy Facility, Commercialization & Industrialization Project")
Inside A Gene Therapy Facility, Commercialization & Industrialization ProjectAn inside look at a clinical-stage company focused on bringing its gene therapy from the lab into a clinical setting for patients and families devastated by rare neurological genetic diseases.
-
![GettyImages-1425605790 Life Sciences Training. Scientists Using A Computer In A Lab]( "Treating Deficiencies In Employee Training And Mentorship")
Treating Deficiencies In Employee Training And MentorshipInvesting in employee training and development is not just beneficial for the employees. It also contributes significantly to the organization’s success and competitive advantage.
-
![GettyImages-184945838-cold-chain-cryopreservation]( "Prepping For Commercialization Through Supply Chain Logistics")
Prepping For Commercialization Through Supply Chain LogisticsWhile cell and gene therapies are bringing new hope to patients experiencing rare and serious diseases, uncover how they're disrupting the biopharma market in new and challenging ways.
-
![GettyImages-1359760465 doctor ipad]( "Unified Platform Supports Rapid Implementation Of Rescue Study")
Unified Platform Supports Rapid Implementation Of Rescue StudyExplore how these integrated solutions helped an emerging biopharma to implement a plan for study build and migration with minimal disruption to sites.
-
![Medicine-pills-tablets-GettyImages-545993684]( "RTSM And Clinical Drug Dispensation")
RTSM And Clinical Drug DispensationA pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.
-
![Scientist research laboratory pipette GettyImages-487041629]( "Overcoming The Complex Logistics Of Autologous Cell Therapy Trials: A Deep Dive Into Challenges And Solutions")
Overcoming The Complex Logistics Of Autologous Cell Therapy Trials: A Deep Dive Into Challenges And SolutionsExplore critical logistical requirements in autologous cell therapies logistics and learn how to overcome challenges and achieve successful and timely autologous cell therapy trials.
-
![ERP]( "How Pharmaceutical Manufacturers Can Take Control Of Their Supply Chain")
How Pharmaceutical Manufacturers Can Take Control Of Their Supply ChainIn an increasingly competitive and regulated landscape, the right ERP system is no longer optional—it’s essential to reclaim control and drive growth in pharmaceutical manufacturing.
-
![GettyImages-1404326328 computer, research]( "From Frustration To Organization: An SSO Platform For Trial Sites")
From Frustration To Organization: An SSO Platform For Trial SitesTo reap the benefits of tech innovation, sponsors and sites need a single sign-on (SSO) solution that enables streamlined organization across different trials and clinical systems.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
